Responses
Journal review
Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial
Compose a Response to This Article
Other responses
No responses have been published for this article.